Literature DB >> 10216001

Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas.

H Haapasalo1, S Sallinen, P Sallinen, P Helén, J Jääskeläinen, T T Salmi, A Paetau, L Paljärvi, T Visakorpi, H Kalimo.   

Abstract

We have analysed 78 cerebellar pilocytic astrocytomas to assess whether histopathology, cell proliferation, apoptosis rate, p53 immunoreactivity, or flow cytometry could predict their long-term behaviour. Classic pilocytic/microcystic pattern was seen in 62 patients and 16 patients had mixed pattern with an additional non-pilocytic glial component. The overall 5-year survival was 93%, complete resection providing 100% survival. The four patients who died during the follow-up were more than 14 years of age, their primary operation had been incomplete and three of them were mixed variants. In 15 cases the tumour recurred giving a recurrence-free 5-year survival of 77%. The proliferation indices were low: Ki-67MIB-1 (median 2.0%), PCNA (1.2%) and S-phase fraction (4.4%). The Ki-67MIB-1-labelling index was significantly higher in young patients, but did not differ between the classic and mixed variants. Twenty-two per cent of the tumours were aneuploid with a significantly higher S-phase fraction than in diploid tumours. p53 seems to act as ardian of the genome' in pilocytic astrocytomas, because aberrant/increased expression of p53 and aneuploidy associated with enhanced apoptosis. Only patient age (P = 0.01), radicality of the primary operation (P = 0.0001) and histology (classic vs mixed, P=0.008) significantly correlated with survival. The poorer prognosis of the mixed variant suggests that this may represent a distinct entity. Although none of the novel parameters significantly predicted recurrence or survival, they indicate substantial biological variation among cerebellar pilocytic astrocytomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216001     DOI: 10.1046/j.1365-2990.1999.00157.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  10 in total

1.  Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy.

Authors:  Joonas Haapasalo; Kristiina Nordfors; Sally Järvelä; Helena Bragge; Immo Rantala; Anna-Kaisa Parkkila; Hannu Haapasalo; Seppo Parkkila
Journal:  Neuro Oncol       Date:  2007-04-13       Impact factor: 12.300

Review 2.  P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature.

Authors:  Georgia Levidou; Elias El-Habr; Angelica A Saetta; Christine Bamias; Klea Katsouyanni; Klea Katsougiannis; Efstratios Patsouris; Penelope Korkolopoulou
Journal:  J Neurooncol       Date:  2010-05-12       Impact factor: 4.130

3.  Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS.

Authors:  M Utriainen; M Komu; V Vuorinen; P Lehikoinen; P Sonninen; T Kurki; T Utriainen; A Roivainen; H Kalimo; H Minn
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

4.  Sub-classification of low-grade cerebellar astrocytoma: is it clinically meaningful?

Authors:  Tine Bernhardtsen; Henning Laursen; Marie Bojsen-Møller; Flemming Gjerris
Journal:  Childs Nerv Syst       Date:  2003-09-30       Impact factor: 1.475

5.  CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity.

Authors:  Pauliina Filppu; Jayendrakishore Tanjore Ramanathan; Kirsi J Granberg; Erika Gucciardo; Hannu Haapasalo; Kaisa Lehti; Matti Nykter; Vadim Le Joncour; Pirjo Laakkonen
Journal:  JCI Insight       Date:  2021-05-10

6.  Activation of the Hedgehog pathway in pilocytic astrocytomas.

Authors:  Sarah Z Rush; Ty W Abel; Juan G Valadez; Matthew Pearson; Michael K Cooper
Journal:  Neuro Oncol       Date:  2010-03-11       Impact factor: 12.300

7.  Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas.

Authors:  Mari Valkonen; Hannu Haapasalo; Kirsi Rilla; Kristiina Tyynelä-Korhonen; Ylermi Soini; Sanna Pasonen-Seppänen
Journal:  BMC Cancer       Date:  2018-06-18       Impact factor: 4.430

8.  Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.

Authors:  Hidehiro Takei; Subashini T Yogeswaren; Kwong-Kwok Wong; Vidya Mehta; Murali Chintagumpala; Robert C Dauser; Ching C Lau; Adekunle M Adesina
Journal:  J Neurooncol       Date:  2007-08-10       Impact factor: 4.506

9.  Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas.

Authors:  Katri Mäkelä; Kristiina Nordfors; Jukka Finne; Anne Jokilammi; Timo Paavonen; Hannu Haapasalo; Miikka Korja; Joonas Haapasalo
Journal:  BMC Cancer       Date:  2014-08-28       Impact factor: 4.430

10.  Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.

Authors:  Kirsi J Granberg; Matti Annala; Birgitta Lehtinen; Juha Kesseli; Joonas Haapasalo; Pekka Ruusuvuori; Olli Yli-Harja; Tapio Visakorpi; Hannu Haapasalo; Matti Nykter; Wei Zhang
Journal:  Neuro Oncol       Date:  2017-09-01       Impact factor: 12.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.